Title: Omnibus Solicitation for SBIR and STTR Grant Applications Program Announcements Requests for Applica
1Omnibus Solicitation for SBIR and STTR Grant
ApplicationsProgram AnnouncementsRequests for
Applications
2Probes and Instruments for Micro-Imaging the
BrainReleased October 23, 1998 Program
Announcement No. PA-98-007
3Sponsoring NIH Institutes
- National Institute of Mental Health
4Sponsoring NIH Institutes
- National Institute of Mental Health
- National Institute on Deafness and Other
Communication Disorders
5Application Receipt Dates
- April 1, August 1, and December 1
6Application Receipt Dates
- April 1, August 1, and December 1
- 1998, 1999, and 2000
7Application Receipt Dates
- April 1, August 1, and December 1
- 1998, 1999, and 2000
- Reactivation is anticipated
8Purpose of PA
- Tools and approaches to image the structure and
function of subcellular elements in the nervous
system.
9Two Thrusts for Research and Development
- Novel probes to generate signals reflecting
- processes and structures in cells of the nervous
system
10Two Thrusts for Research and Development
- Novel probes to generate signals reflecting
- processes and structures in cells of the nervous
system - Novel instruments (including software) with which
to detect and analyze those signals
11Projects Relevant to this PA
- Very small, sterically benign probes that can be
linked genetically to proteins that play
important roles in cell function
12Projects Relevant to this PA
- Very small, sterically benign probes that can be
linked genetically to proteins that play
important roles in cell function - High speed multi-photon microscopy to track the
movement, and quantitate the amount of probes
reporting intracellular processes
13Duration and Award Levels
14Duration and Award Levels
15Phase I
16Phase I
- Maximum duration 2 years
- Maximum award 400,000 for both years (i.e.,
200,000 per year, on average), total costs.
17Phase II
18Phase II
- Maximum duration 3 years
- Maximum award 1.35 million for all three years
(i.e., 450,000 per year, on average), total
costs.
19Phase I and II
- Maximum duration 5 years
- Maximum award 1.75 million, total costs
20Bioengineering Nanotechnology InitiativeReleased
December 2, 1999Program Announcement No.
PA-00-018
21Initiated by the Trans-NIH BioEngineering
CONsortium (BECON)
22Sponsoring NIH Institutes and Centers
- National Cancer Institute
- National Center for Research Resources
- National Eye Institute
- National Human Genome Research Institute
- National Heart, Lung, and Blood Institute
- National Institute on Aging
- National Institute on Alcohol Abuse and Alcoholism
23Sponsoring NIH Institutes and Centers
- National Institute of Allergy and Infectious
Diseases - National Institute of Arthritis and
Musculoskeletal and Skin Diseases - National Institute of Child Health and Human
Development - National Institute on Drug Abuse
- National Institute on Deafness and Other
Communication Disorders
24Sponsoring NIH Institutes and Centers
- National Institute of Dental and Craniofacial
Research - National Institute of Diabetes and Digestive and
Kidney Diseases - National Institute of Environmental Health
Sciences - National Institute of General Medical Sciences
- National Institute of Mental Health
- National Institute of Neurological Disorders and
Stroke - National Library of Medicine
25Application Receipt Dates
- April 1, August 1, and December 1
26Application Receipt Dates
- April 1, August 1, and December 1
- 2000, 2001, and 2002
27Purpose of PA
- Nanotechnologies useful to biomedicine
28Definition of Nanotechnology
- The creation of functional materials, devices and
systems through control of matter at the scale of
1 to 100 nanometers, and the exploitation of
novel properties and phenomena at the same scale.
29Why Nano Now at NIH?
- Nanotechnology is emerging as a field of great
promise for biomedicine
30Why the SBIR Program?
- Nanotechnologies may form the foundation of
significant commercial platforms
31Projects Relevant to this PA
- Development of nanofabricated barriers to prevent
rejection of implantable materials
32Projects Relevant to this PA
- Development of nanofabricated barriers to prevent
rejection of implantable materials - Development of nanoparticles and nanospheres that
enable controlled release of therapeutic agents,
antibodies, genes and vaccines into targeted cells
33Duration and Award Levels
34Phase I
35Phase I
- Maximum duration 2 years
- Maximum award 400,000 for both years (i.e.,
200,000 per year, on average), total costs.
36Phase II
37Phase II
- Maximum duration 3 years
- Award level 1.2 million for all three years
(i.e., 400,000 per year, on average), total
costs.
38Phase I and II
- Maximum duration 5 years
- Award level 1.6 million, total costs